Business Services Industry
VIVUS Announces Second Supplier of Alprostadil
Business Wire, Jan 8, 1996
MENLO PARK, Calif.--(BUSINESS WIRE)--Jan. 8, 1996--VIVUS, Inc. (NASDAQ: VVUS) today announced that it has entered into a long-term supply agreement with Chinoin Pharmaceutical and Chemical Works Co., Ltd. for alprostadil, the drug substance used in VIVUS' anticipated first product, MUSE (alprostadil).
Chinoin is a Hungarian subsidiary of the French pharmaceutical company Sanofi Winthrop. Chinoin now becomes the second source of alprostadil for VIVUS.
"This agreement represents another significant milestone achieved by VIVUS," said Leland F. Wilson, president and chief executive officer. "Having two high quality suppliers of alprostadil significantly reduces our supply risk."
Alprostadil is a synthetic version of prostaglandin E1, a naturally-occurring blood vessel dilator. VIVUS expects to include Chinoin as a second source for alprostadil in its New Drug Application, planned for submission to the U.S. Food and Drug Administration during the first quarter 1996.
Founded in 1991, VIVUS is a leader in the development of advanced therapeutic systems for the treatment of erectile dysfunction, commonly referred to as impotence. The company has pioneered a unique therapy for erectile dysfunction, known as the transurethral system for erection. This therapy consists of a proprietary, non-invasive, drug-delivery system that delivers pharmacologic agents via the urethra.
CONTACT: VIVUS, Inc.
David Yntema or Barbara Clark, 415/325-5511
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Content provided in partnership with
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
Presented by American Express